Enanta Pharmaceuticals
ENTA
#7977
Rank
ยฃ0.27 B
Marketcap
ยฃ9.56
Share price
-1.31%
Change (1 day)
60.10%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -ยฃ38.14 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ69.21 Million. In 2025 the company made an earning of -ยฃ47.87 Million, an increase over its 2024 earnings that were of -ยฃ72.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ38.14 Million-20.32%
2025 -ยฃ47.87 Million-34.07%
2024 -ยฃ72.6 Million-23.87%
2023 -ยฃ95.36 Million4.39%
2022 -ยฃ91.36 Million-4.4%
2021 -ยฃ95.56 Million91.12%
2020 -ยฃ50.01 Million-407.13%
2019 ยฃ16.28 M-78.63%
2018 ยฃ76.19 M117.97%
2017 ยฃ34.95 M-574.65%
2016 -ยฃ7.37 Million-110.83%
2015 ยฃ68.01 M-4.5%
2014 ยฃ71.22 M-638.53%
2013 -ยฃ13.23 Million-137.98%
2012 ยฃ34.81 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.44 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.81 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ4.47 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.78 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.84 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.18 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA